相关实验视频

Updated: Sep 17, 2025

Efficient iPS Cell Generation from Blood Using Episomes and HDAC Inhibitors

Efficient iPS Cell Generation from Blood Using Episomes and HDAC Inhibitors

Published on: October 28, 2014

血液学中的表观遗传革命:从临床突破到临床转型

Mahdis Abdar Esfahani¹, Nazli Servatian², Ali Jihad Hemid Al-Athari³

¹Student Research Committee, Department of Hematology and Blood Banking, School of Allied Medical Sciences, Bushehr University of Medical Sciences, Bushehr, Iran.

Clinical and experimental medicine

|July 2, 2025

概括

表观遗传改变驱动血液癌症,如急性髓性白血病. 表观遗传疗法提供了一种有希望的方法来逆转这些变化并改善患者的治疗结果.

科学领域:

血液学血液学血液学
表观遗传学在表观遗传学中,表观遗传学是指表观遗传学.
在瘤学瘤学.

背景情况:

表观遗传过程,包括DNA甲基化和基因组修饰,在血液性恶性瘤中至关重要.
异常的表观遗传变化有助于基因表达放松调节和白血病发生.

研究的目的:

审查表观遗传改变在血液恶性瘤中的作用.
讨论当前和新兴的表观遗传疗法.
突出这一领域的挑战和未来方向.

主要方法:

在血液癌症中的表观遗传机制的文献综述.
对表观遗传疗法的分析,包括抑制剂和新方法.
讨论挑战和未来的研究需求.

主要成果:

表观遗传修饰显著影响急性骨髓性白血病和骨髓质综合征的发展.
表观遗传疗法 (例如,DNMT,HDAC,EZH2抑制剂) 显示出扭转异常表观遗传变化的潜力.
结合疗法和基于CRISPR的编辑等创新策略正在出现.

结论:

表观遗传疗法在治疗血液性恶性瘤方面具有变革性的潜力.
需要进一步的研究来克服诸如非目标效应和耐药性等挑战.
精准医学方法对于为个别患者量身定制表观遗传疗法至关重要.

关键词:

基于CRISPR的治疗方法组合疗法是一种联合疗法.表观遗传修饰表观遗传修饰表观遗传修饰血液学的恶性瘤.精准医学是一门精准的医学.

更多相关视频

An Integrated Platform for Genome-wide Mapping of Chromatin States Using High-throughput ChIP-sequencing in Tumor Tissues

An Integrated Platform for Genome-wide Mapping of Chromatin States Using High-throughput ChIP-sequencing in Tumor Tissues

Published on: April 5, 2018

Hemogenic Reprogramming of Human Fibroblasts by Enforced Expression of Transcription Factors

Hemogenic Reprogramming of Human Fibroblasts by Enforced Expression of Transcription Factors

Published on: November 4, 2019

相关概念视频

Lineage Commitment

Lineage Commitment

Commitment is the process whereby stem cells:

Hematopoiesis

Hematopoiesis

The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...

Bone Marrow Sampling and Transplants

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...